MiR-101: An Important Regulator of Gene Expression and Tumor Ecosystem

被引:11
|
作者
Liu, Ning [1 ]
Yang, Chunsheng [1 ]
Gao, Ang [1 ]
Sun, Meili [1 ]
Lv, Deguan [2 ]
机构
[1] Shandong First Med Univ, Cent Hosp, Dept Oncol, Jinan 250013, Peoples R China
[2] Univ Pittsburgh, UPMC Hillman Canc Ctr, Pittsburgh, PA 15232 USA
关键词
miR-101; microenvironment; suppressor; proliferation; migration; invasion; apoptosis; therapy; BREAST-CANCER CELLS; GROWTH-FACTOR-C; LUNG-CANCER; INDUCED APOPTOSIS; MESENCHYMAL TRANSITION; COLORECTAL-CANCER; BLADDER-CANCER; COLON-CANCER; PROLIFERATION; MICRORNA-101;
D O I
10.3390/cancers14235861
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Abnormal expression of miRNA is often observed in cancer. MiR-101 is closely associated with tumor initiation and progression. In this review, we summarized new findings regarding the role of miR-101 in cancer and the potential mechanisms of targeted gene degradation and microenvironmental regulation. MiRNAs are small single-stranded non-coding RNAs. MiRNA contributes to the transcriptional and post-transcriptional regulation of mRNA in different cell types, including mRNA transcription inhibition and mRNA decay and phenotypes via the effect of several essential oncogenic processes and tumor microenvironment. MiR-101 is a highly conserved miRNA that was found to alter the expression in various human cancers. MiR-101 has been reported to have tumor oncogenic and suppressive effects to regulate tumorigenesis and tumor progression. In this review, we summarize the new findings about the roles of miR-101 in cancers and the underlying mechanisms of targeting genes degradation and microenvironment regulation, which will improve biological understanding and design of novel therapeutics.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Diagnostic and prognostic implications of serum miR-101 in osteosarcoma
    Yao, Z. -S.
    Li, C.
    Liang, D.
    Jiang, X. -B.
    Tang, J. -J.
    Ye, L. -Q.
    Yuan, K.
    Ren, H.
    Yang, Z. -D.
    Jin, D. -X.
    Zhang, S. -C.
    Ding, J. -Y.
    Tang, Y. -C.
    Xu, J. -X.
    Chen, K.
    Xie, W. -X.
    Guo, D. -Q.
    Cui, J. -C.
    CANCER BIOMARKERS, 2018, 22 (01) : 127 - 133
  • [2] MiR-101: a potential therapeutic target of cancers
    Wang, Cen-Zhu
    Deng, Fei
    Li, Hao
    Wang, Dan-Dan
    Zhang, Wei
    Ding, Li
    Tang, Jin-Hai
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (11): : 3310 - 3321
  • [3] The role of miR-101 in esophageal and gastric cancer
    Syllaios, Athanasios
    Sakellariou, Stratigoula
    Garmpis, Nikolaos
    Sarlani, Eleni
    Damaskos, Christos
    Apostolou, Konstantinos
    Kykalos, Stylianos
    Gazouli, Maria
    Karavokyros, Ioannis
    Schizas, Dimitrios
    PERSONALIZED MEDICINE, 2021, 18 (05) : 491 - 499
  • [4] Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth
    He, Xiao-Pu
    Shao, Yun
    Li, Xiao-Lin
    Xu, Wei
    Chen, Guo-Sheng
    Sun, Huan-Huan
    Xu, Hai-Chen
    Xu, Xian
    Tang, Dan
    Zheng, Xi-Feng
    Xue, Yi-Ping
    Huang, Guo-Chang
    Sun, Wei-Hao
    FEBS JOURNAL, 2012, 279 (22) : 4201 - 4212
  • [5] IN-VITRO TRANSFECTION OF ANTI-TUMOR miR-101 INDUCES BIM, A PRO-APOPTOTIC PROTEIN, EXPRESSION IN ACUTE MYELOID LEUKEMIA (AML)
    Lotfabadi, Narges Nikoonahad
    Kouchesfahani, Homa Mohseni
    Sheikhha, Mohammad Hasan
    Kalantar, Seyed Mehdi
    EXCLI JOURNAL, 2017, 16 : 1257 - 1267
  • [6] Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101
    Lv, Xuecheng
    Li, Jinghua
    Yang, Bingnan
    ONCOLOGY REPORTS, 2016, 36 (04) : 2184 - 2192
  • [7] Elevated miR-101 Reduces Resistance of Cervical Carcinoma CaSki Cells to Cisplatin by Inhibiting the Expression of mTOR miR-101 and Cervical Cancer Cell Cisplatin Resistance
    Hu, Jinghui
    Wang, Li
    Shen, Heping
    Huang, Yujie
    Zhao, Wei
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2018, 8 (03) : 426 - 432
  • [8] MiR-101 acts as a novel bio-marker in the diagnosis of bladder carcinoma
    Chen, Xiaoyan
    MEDICINE, 2019, 98 (26) : e16051
  • [9] MiR-101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma
    Xu, Fei
    Liao, Jia-Zhi
    Xiang, Guang-Ya
    Zhao, Peng-Xuan
    Ye, Feng
    Zhao, Qiu
    He, Xing-Xing
    CANCER MEDICINE, 2017, 6 (03): : 651 - 661
  • [10] The Expression Patterns and Implications of MALAT1, MANCR, PSMA3-AS1 and miR-101 in Esophageal Adenocarcinoma
    Syllaios, Athanasios
    Gazouli, Maria
    Vailas, Michail
    Mylonas, Konstantinos S.
    Sakellariou, Stratigoula
    Sougioultzis, Stavros
    Karavokyros, Ioannis
    Liakakos, Theodoros
    Schizas, Dimitrios
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)